PTEN and cancer: The research indicates that CPhGs upregulate P53 protein levels and trigger cellular apoptotic pathways by inhibiting the SIRT2‐MDM2/P300 and PI3K/AKT signaling pathways while activating the PTEN‐Bax cancer suppressor signal.